For the Patient Only

This article was placed on behalf of the U.S. based equity research effort of institutional broker and investment bank Canaccord Genuity. It was part of a series of articles developed under an agreement with to work with a variety of contributors and assist them in delivering actionable investment ideas each week. The site, is one of the top 500 sites in the world with nearly 10 million subscribers and approximately 100 million page views a month.

Following Q4 (AMZN) earnings, Canaccord Genuity Internet technology analyst Michael Graham reiterated his HOLD rating on the company and lowered his price target to $210 from $225. Mr. Graham said:

“While we are bullish on Amazon’s very long-term prospects and ultimate share of global retail, we remain of the view that the stock may see continued pressure, especially relative to robust growth elsewhere in the sector, until profitability can recover. We believe management is running the business essentially at break-even as a matter of design while the company reaches for ever-expanding market share, and we think marginal investors will continue to lose patience with this strategy in the medium term.

We are lowering our price target from $225 to $210. Our new target is based on a 25x P/E applied to our 2015 pro forma EPS estimate of $12.59, discounted to the present at a rate of 10.7%.

We have noted previously that the stock seems to bottom at around 1.3x revenue, and note that the stock traded after hours following the earnings call at around $178 which is very close to 1.3x our new 2012 revenue estimate. However, with revenue estimates likely to come down, we believe there could be a temporary dip below this support level. “

More Posts

Scroll to Top